Papillary thyroid cancer (PTC) is the most common tumor subtype of thyroid cancer.
However, not all PTCs are responsive to current surgical and radioiodine treatment. The well …

Background Because lymph node (LN) metastasis has been proven to be a predictor for
locoregional recurrence (LRR) in papillary thyroid microcarcinoma (PTMC), better …

Context: BRAFV600E is considered a negative prognostic marker in papillary thyroid
carcinoma (PTC), but unexplained conflicting results are present in the literature. In light of …

Background: While the association of the BRAFV600E mutation with aggressive
histopathological tumor features and clinical behavior has been extensively studied in …

Thyroid cancer is a common malignancy of endocrine system, and has now become the
fastest increasing cancer among all the malignancies. The development, progression …

Thyroid nodules are common in the adult population where a majority are benign and only
4.0% to 6.5% are malignant. Fine needle aspiration (FNA) is a key method used in the early …

Context: Radioiodine ablation is commonly used to treat thyroid cancer, but a major
challenge is often the loss of radioiodine avidity of the cancer caused by aberrant silencing …

Background: The BRAF mutation has been shown to be associated with aggressive
clinicopathologic characteristics of papillary thyroid cancer (PTC). However, several studies …

Purpose To investigate whether a computer-aided diagnosis (CAD) program developed
using the deep learning convolutional neural network (CNN) on neck US images can predict …

Purpose To identify specific novel genes that could be used as diagnostic and prognostic
factors in papillary thyroid carcinoma (PTC). Methods Screening of differential genes by …